🧵🤰💊 Managing Rheumatoid Arthritis during pregnancy & breastfeeding isn’t just about the right meds — it’s about timing, planning, and protecting both mum & baby.
Here’s your evidence-based, easy-to-follow guide 👇
@IhabFathiSulima @DrAkhilX @CelestinoGutirr @DurgaPrasannaM1 @RA_information #MedTwitter #Rheumatology
1️⃣ Planning is key
RA and pregnancy can coexist safely with the right plan.
Pre-pregnancy counselling is essential — discuss disease control, medication safety, and timing of conception.
2️⃣ Disease activity matters
Best pregnancy outcomes happen when RA is in remission or low activity for ≥3–6 months before conception.
Active disease → ↑ risk of miscarriage, preterm birth, and growth restriction.
3️⃣ Pre-pregnancy medication check
Some drugs must be stopped well before conception:
❌ Methotrexate — stop ≥3 months before
❌ Leflunomide — cholestyramine washout needed
❌ Cyclophosphamide — avoid completely
✅ Hydroxychloroquine, sulfasalazine, low-dose steroids are safe
4️⃣ Biologics & tsDMARDs
•Certolizumab pegol: safest TNF inhibitor in pregnancy (minimal placental transfer)
•Etanercept, adalimumab, infliximab: can be used until 20–30 weeks if needed
•Avoid JAK inhibitors & abatacept in pregnancy
5️⃣ NSAIDs
•Can be used in 1st & 2nd trimesters if essential
•Avoid after 30 weeks (risk of ductus arteriosus closure)
6️⃣ Monitoring in pregnancy
•Multidisciplinary approach: rheumatology + obstetrics
•Monitor disease activity every trimester
•Keep steroid dose as low as possible (ideally ≤7.5 mg prednisolone)
7️⃣ Delivery planning
RA itself isn’t an indication for C-section.
Mode of delivery depends on obstetric indications — but hand, wrist, or hip involvement may affect labour positions.
8️⃣ Breastfeeding — drug safety
Most RA-safe pregnancy drugs are also safe in breastfeeding:
✅ Hydroxychloroquine, sulfasalazine, low-dose prednisolone, most TNF inhibitors
❌ Methotrexate, leflunomide, cyclophosphamide — avoid
💡 Prednisolone >20 mg/day: wait 4 hrs after dose before feeding
9️⃣ Flares after delivery
Up to 40–50% of women flare postpartum.
Plan follow-up within the first 6 weeks to adjust meds promptly.
🔟 Key take-home
•Plan early, aim for remission
•Choose pregnancy-safe meds
•Continue care into postpartum period
•RA control protects both mother & baby
💬 Have you managed RA in pregnancy in your practice?
What’s been your biggest challenge? Let’s discuss 👇
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Gout is the most common inflammatory arthritis, yet nearly 80% of patients are suboptimally managed, leading to preventable flares, tophi, and joint damage.
Forget the old myths of “kings and diet.”
Here is the modern, evidence-based approach to gout management, aligned with ACR guidelines, for the busy clinician. 🧵
MYTH: Gout is purely a “lifestyle disease” fixed by diet.
FACT: Diet typically alters serum urate by ~1 mg/dL at most.
Gout is primarily a genetically determined disorder of renal urate under-excretion.
You cannot “diet away” established gout. Medication is usually required.
Tweet 3 - The Goal (Treat-to-Target)
The goal of therapy isn’t just stopping flares - it’s dissolving monosodium urate crystals.
That requires a Treat-to-Target strategy:
• Target serum urate < 6.0 mg/dL for all gout patients
• If tophi are present: < 5.0 mg/dL for faster crystal clearance
The Clinical Approach to a Positive Antinuclear Antibody (ANA):
A positive ANA is one of the most common consults in Internal Medicine, yet it is widely misunderstood.
Positive ANA ≠ Lupus.
It causes significant patient anxiety and unnecessary referrals.
Here is the evidence-based approach to interpreting a positive ANA for the busy clinician. 🧵
#MedEd #Rheumatology #MedTwitter @DrAkhilX @IhabFathiSulima #InternalMedicine #Lupus #MedicalEducation
First, understand the pre-test probability.
ANA is not a screening test for fatigue or nonspecific pain.
Why? Up to 20–30% of the healthy population has a positive ANA at 1:40 titer. Even at 1:160, ~5% of healthy individuals are positive.
#Diagnostics #ClinicalPearls #PrimaryCare
The Titer is the key to specificity.
• 1:40 to 1:80: Low positive. Low clinical significance in isolation.
• 1:160: Intermediate.
• ≥ 1:320: High positive. Higher specificity for autoimmune disease, but still requires clinical correlation.
Treat the patient, not the number.
Ozempic vs Mounjaro — the REAL 2025 comparison.
🧵Thread🔥👇
Everyone is talking about weight-loss drugs. But the REAL showdown is Ozempic vs Mounjaro — and the winner is clear.
Ozempic and Mounjaro should be prescribed ONLY after medical assessment — never self-started.
🧵 5 Lab Traps That Delay Lupus Diagnosis (with one example)
I’ve seen lupus hide behind “normal” labs more times than I can count.
Here are 5 lab traps that delay the diagnosis — with one real case that’ll stick with you. 🧵👇
@DrAkhilX @IhabFathiSulima @DrNikhilMD @Janetbirdope @DurgaPrasannaM1 #MedTwitter #RheumTwitter #Autoimmunity
1️⃣ “ANA is negative, so it’s not lupus.”
Wrong.
Early SLE can have low-titer or even transiently negative ANA.
🧠 If your gut says lupus, repeat it after a few weeks.
2️⃣ “CRP is high, so it must be infection.”
Not always.
Lupus flares often have normal CRP.
High CRP just means: check if there’s serositis, arthritis… or yes, infection.